Aurobindo Pharma Limited Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA

Rang in Aktien #2072
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Aktienkurs
$17.34
Marktkapitalisierung
$9.98B
Veränderung (1 Tag)
-3.08%
Veränderung (1 Jahr)
38.71%
Land
IN
Handel Aurobindo Pharma Limited (AUROPHARMA)

Kategorie

Healthcare
Aktien-Split-Historie für Aurobindo Pharma Limited (AUROPHARMA)
Die Aktie Aurobindo Pharma Limited (Symbol: AUROPHARMA) durchlief insgesamt 5 Aktiensplits.
Der letzte Aktiensplit fand am Jul 20, 2015 statt.
Eine AUROPHARMA-Aktie, die vor dem Oct 26, 1998 gekauft wurde, entspricht heute 80 AUROPHARMA-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2015-07-20 2:1 x2 x80
2011-02-10 5:1 x5 x40
2003-10-23 2:1 x2 x8
2000-03-20 2:1 x2 x4
1998-10-26 2:1 x2 x2
Aktiensplits ähnlicher Unternehmen oder Wettbewerber